Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wu Pan

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
Oncotarget|March 10, 2016
Overexpression of USP39 predicts poor prognosis and promotes tumorigenesis of prostate cancer via promoting EGFR mRNA maturation and transcription elongationYi Huang, Xiu-Wu Pan, Lin Li, et al.
Ebiomedicine|December 19, 2018
Gankyrin is a novel biomarker for disease progression and prognosis of patients with renal cell carcinomaChao Wang, Yan Li, Chuan-Min Chu, et al.
Cell Death & Disease|July 27, 2024
DEPDC1 as a metabolic target regulates glycolysis in renal cell carcinoma through AKT/mTOR/HIF1α pathwaySi-Chen Di, Wen-Jin Chen, Wei Yang, et al.
Cell Death & Disease|January 12, 2022
Heterogeneity of tumor microenvironment is associated with clinical prognosis of non-clear cell renal cell carcinoma: a single-cell genomics studyWen-Jin Chen, Hao Cao, Jian-Wei Cao, et al.
International Journal of Oncology|September 27, 2016
SMC1A promotes growth and migration of prostate cancer in vitro and in vivoXiu-Wu Pan, Si-Shun Gan, Jian-Qing Ye, et al.
Journal for Immunotherapy of Cancer|July 14, 2025
Unveiling the mechanisms of CEBPD-orchestrated TAM polarization through RGS2/PAR2 pathway and its impact on ICB efficacy in clear cell renal cell carcinomaXiu-Wu Pan, Hong-Feng Zheng, Mu-Chen Li, et al.
International Journal of Oncology|November 9, 2021
[Corrigendum] <i>SMC1A</i> promotes growth and migration of prostate cancer <i>in vitro</i> and <i>in vivo</i>Xiu-Wu Pan, Si-Shun Gan, Jian-Qing Ye, et al.
Journal for Immunotherapy of Cancer|June 22, 2024
Integrated analysis of tertiary lymphoid structures and immune infiltration in ccRCC microenvironment revealed their clinical significances: a multicenter cohort studyYu-Qi Wang, Wen-Jin Chen, Wang Zhou, et al.
Nature Medicine|August 15, 2017
Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1 activationPingzhao Zhang, Dejie Wang, Yu Zhao, et al.
Journal of Extracellular Vesicles|June 2, 2026
Tumour-Derived Extracellular Vesicles Reprogramme Tumour-Associated Macrophages Into Immunosuppressive Phenotype via NOD1 Signalling in Clear Cell Renal Cell CarcinomaXiu-Wu Pan, Mu-Chen Li, Tian-Yue Yang, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Oncotarget|March 10, 2016
Overexpression of USP39 predicts poor prognosis and promotes tumorigenesis of prostate cancer via promoting EGFR mRNA maturation and transcription elongationYi Huang, Xiu-Wu Pan, Lin Li, et al.
Ebiomedicine|December 19, 2018
Gankyrin is a novel biomarker for disease progression and prognosis of patients with renal cell carcinomaChao Wang, Yan Li, Chuan-Min Chu, et al.
Cell Death & Disease|July 27, 2024
DEPDC1 as a metabolic target regulates glycolysis in renal cell carcinoma through AKT/mTOR/HIF1α pathwaySi-Chen Di, Wen-Jin Chen, Wei Yang, et al.
Cell Death & Disease|January 12, 2022
Heterogeneity of tumor microenvironment is associated with clinical prognosis of non-clear cell renal cell carcinoma: a single-cell genomics studyWen-Jin Chen, Hao Cao, Jian-Wei Cao, et al.
International Journal of Oncology|September 27, 2016
SMC1A promotes growth and migration of prostate cancer in vitro and in vivoXiu-Wu Pan, Si-Shun Gan, Jian-Qing Ye, et al.
Journal for Immunotherapy of Cancer|July 14, 2025
Unveiling the mechanisms of CEBPD-orchestrated TAM polarization through RGS2/PAR2 pathway and its impact on ICB efficacy in clear cell renal cell carcinomaXiu-Wu Pan, Hong-Feng Zheng, Mu-Chen Li, et al.
International Journal of Oncology|November 9, 2021
[Corrigendum] <i>SMC1A</i> promotes growth and migration of prostate cancer <i>in vitro</i> and <i>in vivo</i>Xiu-Wu Pan, Si-Shun Gan, Jian-Qing Ye, et al.
Journal for Immunotherapy of Cancer|June 22, 2024
Integrated analysis of tertiary lymphoid structures and immune infiltration in ccRCC microenvironment revealed their clinical significances: a multicenter cohort studyYu-Qi Wang, Wen-Jin Chen, Wang Zhou, et al.
Nature Medicine|August 15, 2017
Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1 activationPingzhao Zhang, Dejie Wang, Yu Zhao, et al.
Journal of Extracellular Vesicles|June 2, 2026
Tumour-Derived Extracellular Vesicles Reprogramme Tumour-Associated Macrophages Into Immunosuppressive Phenotype via NOD1 Signalling in Clear Cell Renal Cell CarcinomaXiu-Wu Pan, Mu-Chen Li, Tian-Yue Yang, et al.
Pageof 10